Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs Standard-dose Radiation in Esophageal Carcinoma
NCT01937208Phase 3Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Aug 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, docetaxel in esophageal carcinoma, sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
cisplatindocetaxel
03
Conditions
esophageal carcinoma
Beyond the preview
Go deeper on NCT01937208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937208.